Effects of naldemedine on QT interval in healthy adult volunteers: A placebo and active controlled four-period crossover study

Trial Profile

Effects of naldemedine on QT interval in healthy adult volunteers: A placebo and active controlled four-period crossover study

Completed
Phase of Trial: Phase I

Latest Information Update: 02 Jun 2016

At a glance

  • Drugs Naldemedine (Primary) ; Moxifloxacin
  • Indications Constipation
  • Focus Adverse reactions
  • Most Recent Events

    • 02 Jun 2016 New trial record
    • 14 May 2016 Results presented at the 35th Annual Scientific Meeting of the American Pain Society
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top